Stocks Overview

LAST PRICE
0.4666
TODAY'S CHANGE (%)
Trending Down-0.1004 (-17.7072%)

Bid / Lots
0.4450/ 85
Ask / Lots
0.4460/ 6
Open / Previous Close
0.4780 / 0.5670
Day Range
Low 0.3901
High 0.5000
52 Week Range
Low 0.3625
High 5.4800
Volume
7,597,400
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 0.567
Time	Volume	VRPX
09:32 ET	96247	0.4756
09:33 ET	62487	0.47
09:35 ET	175995	0.4501
09:37 ET	234287	0.439
09:39 ET	169903	0.4354
09:42 ET	156361	0.425001
09:44 ET	38652	0.4279
09:46 ET	55476	0.425
09:48 ET	128202	0.42
09:50 ET	131210	0.4185
09:51 ET	453098	0.41
09:53 ET	74309	0.4029
09:55 ET	80919	0.4
09:57 ET	70982	0.3995
10:00 ET	200269	0.4135
10:02 ET	92367	0.4125
10:04 ET	123364	0.4261
10:06 ET	48535	0.420201
10:08 ET	128857	0.4148
10:09 ET	41145	0.415
10:11 ET	27924	0.4189
10:13 ET	16742	0.4149
10:15 ET	33807	0.4188
10:18 ET	14450	0.4125
10:20 ET	11593	0.416
10:22 ET	53293	0.41
10:24 ET	89464	0.4071
10:26 ET	78160	0.414
10:27 ET	48266	0.42205
10:29 ET	46704	0.4241
10:31 ET	38489	0.4306
10:33 ET	15431	0.4302
10:36 ET	17923	0.436
10:38 ET	7126	0.4421
10:40 ET	11335	0.4419
10:42 ET	38382	0.4367
10:44 ET	6575	0.4439
10:45 ET	43730	0.4439
10:47 ET	25986	0.44
10:49 ET	16163	0.4407
10:51 ET	25231	0.4446
10:54 ET	28700	0.4599
10:56 ET	51786	0.4613
10:58 ET	15757	0.4699
11:00 ET	34671	0.48
11:02 ET	88414	0.48
11:03 ET	31408	0.467
11:05 ET	8527	0.472451
11:07 ET	20346	0.4754
11:09 ET	17394	0.4792
11:12 ET	8737	0.47
11:14 ET	11625	0.4699
11:16 ET	68839	0.47
11:18 ET	9860	0.4602
11:20 ET	10254	0.4645
11:21 ET	2600	0.4645
11:23 ET	37386	0.4572
11:25 ET	7007	0.4604
11:27 ET	21412	0.4686
11:30 ET	6215	0.4769
11:32 ET	16999	0.47
11:34 ET	8608	0.47
11:36 ET	3239	0.4647
11:38 ET	12407	0.475
11:39 ET	11340	0.464001
11:41 ET	11295	0.468
11:43 ET	7052	0.4617
11:45 ET	20262	0.47
11:48 ET	871	0.47
11:50 ET	24760	0.463
11:52 ET	15160	0.4699
11:54 ET	1350	0.4699
11:56 ET	5388	0.4557
11:57 ET	1081	0.4659
11:59 ET	3442	0.4658
12:01 ET	23812	0.4655
12:03 ET	15529	0.47
12:06 ET	4640	0.465
12:08 ET	19727	0.48
12:10 ET	16602	0.472
12:12 ET	2485	0.468
12:14 ET	137262	0.4437
12:15 ET	2788	0.4564
12:17 ET	750	0.4509
12:19 ET	6241	0.465
12:21 ET	500	0.4649
12:24 ET	1100	0.4516
12:26 ET	2122	0.4646
12:28 ET	1663	0.46
12:30 ET	4812	0.4599
12:32 ET	3025	0.4598
12:33 ET	47546	0.4599
12:35 ET	8802	0.4648
12:37 ET	2100	0.4649
12:39 ET	15405	0.4687
12:42 ET	13820	0.4687
12:44 ET	22115	0.4599
12:46 ET	1200	0.4607
12:48 ET	21444	0.4603
12:50 ET	800	0.4685
12:51 ET	600	0.4685
12:53 ET	16533	0.468
12:55 ET	32789	0.4677
12:57 ET	3828	0.4677
01:00 ET	3500	0.46
01:02 ET	140851	0.4597
01:04 ET	5145	0.45
01:06 ET	13260	0.4599
01:08 ET	926	0.455
01:09 ET	3901	0.4599
01:11 ET	8800	0.4685
01:13 ET	11200	0.458
01:15 ET	142491	0.455
01:18 ET	16321	0.4466
01:20 ET	16708	0.442
01:22 ET	6796	0.4516
01:24 ET	732	0.4516
01:26 ET	3375	0.4516
01:27 ET	2868	0.4516
01:29 ET	700	0.45
01:31 ET	37110	0.45
01:33 ET	4778	0.45
01:36 ET	7045	0.4499
01:38 ET	83455	0.45
01:40 ET	20747	0.45
01:42 ET	1170	0.4495
01:44 ET	33772	0.45
01:45 ET	42543	0.4611
01:47 ET	13368	0.4677
01:49 ET	84011	0.4435
01:51 ET	8980	0.4428
01:54 ET	1005	0.45
01:56 ET	6700	0.4465
01:58 ET	1747	0.4434
02:00 ET	11260	0.45
02:02 ET	1355	0.45
02:03 ET	14610	0.4598
02:05 ET	3982	0.4598
02:07 ET	7149	0.4598
02:09 ET	12446	0.4598
02:12 ET	45240	0.4599
02:14 ET	1194	0.4457
02:16 ET	9602	0.4499
02:18 ET	9098	0.453
02:20 ET	20438	0.4553
02:21 ET	93977	0.465
02:23 ET	56139	0.465
02:25 ET	8904	0.47
02:27 ET	20750	0.47
02:30 ET	5403	0.4601
02:32 ET	9775	0.455
02:34 ET	900	0.469
02:36 ET	44978	0.4799
02:38 ET	9731	0.4798
02:39 ET	24423	0.4745
02:41 ET	31852	0.46648
02:43 ET	21305	0.4651
02:45 ET	38600	0.4767
02:48 ET	3678	0.475
02:50 ET	1100	0.4748
02:52 ET	3000	0.4735
02:54 ET	2190	0.4719
02:56 ET	8276	0.471
02:57 ET	9304	0.4749
02:59 ET	44334	0.4799
03:01 ET	11678	0.48
03:03 ET	600	0.4839
03:06 ET	23785	0.483
03:08 ET	500	0.4813
03:10 ET	1389	0.472
03:12 ET	3002	0.4777
03:14 ET	10117	0.473
03:15 ET	7117	0.4729
03:17 ET	9277	0.4763
03:19 ET	17901	0.481
03:21 ET	15138	0.4763
03:24 ET	1000	0.4763
03:26 ET	2100	0.479
03:28 ET	2963	0.4777
03:30 ET	4402	0.476
03:32 ET	26654	0.4795
03:33 ET	10433	0.4802
03:35 ET	3615	0.481
03:37 ET	51873	0.4751
03:39 ET	3314	0.4752
03:42 ET	31510	0.4773
03:44 ET	19042	0.4751
03:46 ET	24517	0.4751
03:48 ET	19454	0.4765
03:50 ET	6248	0.4765
03:51 ET	19757	0.475
03:53 ET	7759	0.475
03:55 ET	28035	0.4651
03:57 ET	10300	0.4597
04:00 ET	19708	0.4666

Data delayed at least 15 minutes.

Nov 22, 2024
- Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur(TM), from 8:30AM ET on Friday Nov 22, 2024 by Dow Jones
  8:30AM ET on Friday Nov 22, 2024 by Dow Jones
Nov 21, 2024
- DJ Virpax Pharma Gets Government Cooperation Deal Extension, from 4:41PM ET on Thursday Nov 21, 2024 by Dow Jones
  4:41PM ET on Thursday Nov 21, 2024 by Dow Jones
- Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative, from 4:05PM ET on Thursday Nov 21, 2024 by Dow Jones
  4:05PM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 18, 2024
- Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering, from 10:23AM ET on Monday Nov 18, 2024 by Dow Jones
  10:23AM ET on Monday Nov 18, 2024 by Dow Jones
Nov 15, 2024
- Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants, from 4:09PM ET on Friday Nov 15, 2024 by Dow Jones
  4:09PM ET on Friday Nov 15, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesVRPX Virpax Pharmaceuticals Inc	6.6M	-0.1x	---
United StatesRNAZ Transcode Therapeutics Inc	6.6M	0.0x	---
United StatesBCLI Brainstorm Cell Therapeutics Inc	6.6M	-0.4x	---
United StatesNLSP NLS Pharmaceutics AG	6.8M	-0.5x	---
United StatesADIL Adial Pharmaceuticals Inc	6.5M	-0.2x	---
United StatesNGRC National Graphite Corp	6.8M	-2.0x	---
As of 2024-11-25

Virpax Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company. The Company is focused on developing novel and proprietary drug delivery systems across various pain indication. Its drug-delivery systems and drug-releasing technologies being developed are focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system (CNS) disorders to enhance patients’ quality of life. Its portfolio consists of multiple preclinical stage product candidates: Epoladerm, Probudur, Envelta, AnQlar and NobrXiol. Probudur is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain. Envelta is an intranasal molecular envelope enkephalin formulation being developed to manage acute and chronic pain, including pain associated with cancer. The NobrXiol is being developed for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management of rare pediatric epilepsy.

Contact Information

Headquarters: 1055 Westlakes Drive, Suite 300BERWYN, PA, United States 19312
Phone: 610-727-4597
Fax: 302-636-5454

Executives

Chief Executive Officer, Director: Jatinder Dhaliwal
Chief Financial Officer: Usama Chaudhry
Chief Scientific Officer: Sheila Mathias
Vice President, Director: Katharyn Field
Independent Director: Michael Dubin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$6.6M
Revenue (TTM)	$0.00
Shares Outstanding	11.7M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.00
EPS	$-8.82
Book Value	$1.65
P/E Ratio	-0.1x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Virpax Pharmaceuticals Inc
NASDAQ:VRPXUnited States
NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Search Criteria

Charts

Recent News

Nov 22, 2024

Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur(TM), from 8:30AM ET on Friday Nov 22, 2024 by Dow Jones

Nov 21, 2024

DJ Virpax Pharma Gets Government Cooperation Deal Extension, from 4:41PM ET on Thursday Nov 21, 2024 by Dow Jones

Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative, from 4:05PM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 18, 2024

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering, from 10:23AM ET on Monday Nov 18, 2024 by Dow Jones

Nov 15, 2024

Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants, from 4:09PM ET on Friday Nov 15, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar